Could a targeted clot-buster boost stroke recovery?
NCT ID NCT06781385
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study tests whether giving the clot-busting drug tenecteplase directly into the brain artery after mechanical clot removal is safe and feasible for people with acute ischemic stroke. About 40 adults who had a large-vessel blockage stroke within the last 4.5 to 24 hours will receive the drug during the clot removal procedure. The goal is to see if this approach can improve outcomes without increasing bleeding risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atrium Health Neurosciences Institute
Charlotte, North Carolina, 28207, United States
Conditions
Explore the condition pages connected to this study.